The following tables provide annual data on new diagnoses of HIV (non-AIDS), concurrent HIV/AIDS and AIDS, as well as the number of persons living with HIV and AIDS and the number of deaths among persons with HIV and AIDS. The data are shown for New York City overall and by sex, race, age, borough, area-based poverty level, risk factor, and United Hospital Fund neighborhood.
Glance (Table 1.1) (PDF, one page)
These tables will answer the majority of the most frequently asked questions about HIV in New York City. All percentages appearing in Tables 1.1 – 1.11.4 are column percentages except the total proportion of HIV diagnoses without AIDS and concurrent with AIDS diagnoses, which are row percentages of total HIV diagnoses. Because of rounding, percentages across categories may not sum to 100.0.
Categories containing any cells representing 1-5 person(s) with an underlying denominator of ≤500 people or cells with a denominator ≤100, as per corresponding year intercensal population estimates, are collapsed into the Other/Unknown category. This collapsing of categories is not done in Table 1.1 (all of New York City), Table 1.2.1 (Men), and Table 1.2.2 (Women). Non-residential ZIP codes from the yearly intercensal estimates are excluded from borough-specific population totals but are included in the NYC overall population for the reported year.
For 2001-2010 tables, data are presented by sex at birth. For 2011-2019 tables, data are presented by gender. Surveillance collects information about individuals’ current gender identity, when available. These tables display the following gender categories: men, women, transgender. People whose current gender identity differs from their sex assigned at birth are considered transgender. Classifying transgender people in surveillance requires accurate collection of both sex assigned at birth and current gender identity. Sex and gender information are collected from people’s self-report, their diagnosing provider, or medical chart review. This information may or may not reflect the individual’s self-identification. Transgender identity has been collected routinely since 2005 for newly reported cases. Reported numbers of new transgender HIV diagnoses and transgender people living with HIV (PLWH) are likely to be underestimates. For more information, see the “HIV/AIDS among Transgender people in New York City” surveillance slide set.
Surveillance collects information on other gender identity categories, including “Non-binary/Gender non-conforming.” In these tables, data for these individuals (N=8 at the time of publication) is displayed by sex at birth.
Data on race/ethnicity are derived from multiple sources including patient medical charts, provider reporting, vital statistics records, and patient interviews. Black, White, Asian/Pacific Islander, Native American, and Multiracial race categories exclude Latino/Hispanic ethnicity. Cases with the ethnicity Latino/Hispanic were grouped in the race/ethnicity category Latino/Hispanic, regardless of their race classification. For more information on race definitions, see Technical Notes on Race and Ethnicity Classification in NYC HIV Surveillance Data (PDF).
For 2008-2019 tables, residence is at diagnosis for HIV and AIDS diagnoses; for PLWH and deaths, residence is based on most recent record available (most recent record is >5 years old for 27% of people with HIV in 2019) or residence at death, respectively. For earlier years, residence is at diagnosis for HIV and AIDS diagnoses, and for PLWH and deaths residence is based on residence at AIDS diagnosis if surveillance status is AIDS or residence at HIV diagnosis if HIV-only. Tables for 2008-2019 include area-based poverty level, which is based on NYC ZIP code of residence at diagnosis or most recent record available. Poverty level is not available for people missing ZIP code information or living outside NYC. Please contact the HIV Epidemiology Program at email@example.com if you are interested in additional analyses or have questions about the tables.
New York City HIV/AIDS Annual Surveillance Statistics. New York: New York City Department of Health and Mental Hygiene, 2019. Accessed [access date] at New York City HIV/AIDS Annual Surveillance Statistics.
Acquired immunodeficiency syndrome
Human immunodeficiency virus
HIV-1 is the retrovirus that is responsible for the majority of cases in the world AIDS pandemic.
HIV-2 is a closely related but distinct virus that is found primarily in West Africa and countries with large West African immigrant populations.
More in-depth information regarding HIV Type 2
Injection drug use or injecting drug user
Men who have sex with men
Persons with HIV or AIDS
Persons living with HIV or AIDS. For these tables, PLWHA refers to persons diagnosed and reported in New York City and presumed to be living with HIV/AIDS.
United Hospital Fund neighborhood
Age is calculated as age at diagnosis for HIV and AIDS diagnoses; age as of the end of the calendar year for PLWHA; and age at death for deaths.
Persons are classified as having AIDS if they are HIV-infected and either have one or more AIDS-defining opportunistic illnesses (based on the 1993 CDC case definition) or a laboratory test indicating suppressed CD4+ cell counts (<200 cells/µL).
Clinical status is determined as of the end of the calendar year or at date of death.
An AIDS diagnosis within 31 days of an HIV diagnosis. Persons concurrently diagnosed with HIV and AIDS are included in the totals of both HIV diagnoses and AIDS diagnoses.
A diagnosis of HIV infection is generally based on a positive Western blot test in adults and a positive PCR (polymerase chain reaction) test in infants less than 18 months. Since June 1, 2000, laboratories and health care providers in New York State have been required to report HIV infection even in persons without AIDS.
HIV surveillance captures information about risk factors associated with HIV transmission.
The primary risk factors are men who have sex with men (MSM), injection drug use , history (IDU), MSM-IDU, heterosexual contactand perinatal transmission.
Men who have sex with men includes males with reported sexual contact with another male, and males with no definitive risk and with history of a rectal STI or proctitis.
The injection drug use category includes persons with a history of taking nonprescribed drugs by injection, intravenously, intramuscularly or subcutaneously, excluding men reporting a history of sex with men.
The men reporting a history of sex with men and injection drug use (MSM-IDU) category includes people meeting the definition of both the men who have sex with men and injection drug use categories as described.
The heterosexual category includes persons who had heterosexual sex with an HIV-infected person, an injection drug user, or a person who has received blood products; and for females only, women with a history of heterosexual prostitution, multiple sex partners of the opposite sex, sexually transmitted infection, crack/cocaine use, heterosexual sex with a bisexual male, or unspecified probable heterosexual transmission.
Transgender people with sexual contact includes people identified as transgender at any time by self-report, medical provider or chart review, or ongoing data collection with sexual contact reported and a negative history of injection drug use.
Perinatal transmission is a risk factor for infants who were infected during gestation, birth or postpartum through breastfeeding to an HIV-infected mother.
Other transmission risks include hemophilia, receipt of transfusions or transplants, and non-perinatal risk in pediatric cases (<13 years).
Persons with a risk that is unknown have no risk information reported by the provider or an expanded investigation has not been completed for them.
This corresponds to a geographic area within New York City that is an aggregate of between 1 and 9 ZIP codes but that is smaller than a borough. UHF neighborhoods reflect catchment areas for certain healthcare facilities. See the table and map of UHF neighborhoods and corresponding ZIP codes (PDF).